Cost of covering antiobesity drugs could be billions to Medicare despite, a new analysis finds
If newer brand-name antiobesity medications were covered by Medicare, they could cost the program between $13.6 to $26.8 billion even with only 10% of people with obesity using them, according to a new analysis published in the New England Journal of Medicine by Vanderbilt University Medical Center researchers in the Department of Health Policy.